Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Balzer

Pediatric Cardiology Saint Louis, MO Medical Doctor

NPI 1134147572 CMS profile 323270

1 Childrens Pl, Div Ped Cardiology, Saint Louis, MO 63110

Open in the dashboard

General payments

$180,962

303 records reported · program years 2019–2025

Research payments

$3,750

Paid to them · 9 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$363,096 paid to institutions, not to them · program years 2020–2025

Through program year 2025, David Balzer of Saint Louis, MO is reported in the CMS Open Payments database as having received $180,962 across 303 general payments and $3,750 in research payments paid to them. Separately, studies naming them as principal investigator received $363,096 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Pediatric Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $24,818 38
2025 Research $563 1
2024 General $20,968 37
2024 Research $563 2
2023 General $18,633 36
2023 Research $375 1
2022 General $15,933 44
2021 General $17,695 41
2021 Research $375 1
2020 General $21,886 19
2020 Research $1,500 3
2019 General $61,029 88
2019 Research $375 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Balzer
  • Pediatric Cardiology median
  • Middle half of Pediatric Cardiology
  • National median

In program year 2025, general payments to David Balzer were reported at $24,818. Among 1,168 Pediatric Cardiology profiles paid that year, the median was $146 and the middle half received between $47 and $670.

Show as a table
Year David Balzer Pediatric Cardiology median Middle half National median
2019 $61,029 $124 $35–$516 $163
2020 $21,886 $70 $23–$326 $114
2021 $17,695 $112 $27–$445 $132
2022 $15,933 $129 $36–$680 $149
2023 $18,633 $149 $38–$826 $160
2024 $20,968 $131 $37–$652 $164
2025 $24,818 $146 $47–$670 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $58,375 94 payments
  2. Edwards Lifesciences Corporation $48,932 57 payments
  3. Medtronic, Inc. $39,127 77 payments
  4. Medtronic Vascular, Inc. $34,231 68 payments
  5. Penumbra, Inc. $133 1 payment
  6. Renata Medical, Inc. $58 1 payment
  7. B. Braun Interventional Systems Inc. $47 3 payments
  8. Merit Medical Systems Inc $36 1 payment
  9. Abiomed $24 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $75,119 29 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $44,556 19 payments
  3. Travel and Lodging $32,641 63 payments
  4. Food and Beverage $11,045 187 payments
  5. Royalty or License $10,500 2 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,600 2 payments
  7. Honoraria $3,500 1 payment
Products named General payments · program years 2019–2025
  1. Harmony $34,382 62 payments
  2. AMPLATZER PICCOLO $21,857 33 payments
  3. AMPLATZER Occluders $18,231 17 payments
  4. Melody Heart Valves $15,247 47 payments
  5. AMPLATZER TALISMAN $9,773 6 payments
  6. Edwards SAPIEN 3 Transcatheter Heart Valve $9,494 7 payments
  7. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $8,804 21 payments
  8. CoreValve Evolut $8,152 10 payments
  9. THE EDWARDS SAPIEN 3 VALVE WITH ALTERRA ADAPTIVE PRESTENT SYSTEM $6,807 11 payments
  10. Melody Heart Valves $4,485 9 payments
  11. Other $9,153 58 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $1,875 5 payments
  2. Medtronic Vascular, Inc. $1,875 4 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Pediatric Medicine: 38

Drug cost

$80

Median for Pediatric Medicine: $2,769

Branded share of claims

0%

Median for Pediatric Medicine: 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Warfarin Sodium Generic 13 $80

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,361 Part D prescribers listed as Pediatric Medicine; they describe a distribution and say nothing about conduct.

Records

312 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Cardiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record